NewsBite

Optiscan Imaging

Advertisement
Optiscan Imaging has kicked off pre-clinical trials of its second-generation endomicroscope to test real-time imaging of the gastrointestinal tract.

Optiscan aims for faster diagnoses with new gut health imaging tool

Medtech company Optiscan Imaging has rolled out a flexible endomicroscope prototype capable of capturing real-time images from the gastrointestinal tract.

  • James Pearson

Latest

Optiscan Imaging has teamed up with the University of Minesota in the United States in a research deal to advance cancer research in companion animals using its imaging technology.

Optiscan teams up with Minnesota Uni to enter pet market.

Optiscan and the University of Minnesota Veterinary faculty will team up to determine if Optiscan’s unique cancer detecting imaging tool can be used on pets.

  • James Pearson
Optiscan Imaging recently inked an MOU with the University of Minnesota College of Veterinary Medicine.

Optiscan doubles revenue, boosts profit for Sep qtr

Innovative medical device company Optiscan doubled revenues and tabled its first significant cash profit from sales this year after a news-filled September quarter.

  • Mark Story
Optiscan Imaging MD Dr Camille Farah with the company’s innovative imaging technology which is revolutionising the surgical imaging landscape.

Optiscan roadshows cancer detecting imaging devices in US

Optiscan Imaging has ramped-up its efforts to capture the lucrative US market by roadshowing its innovative medical imaging technology at several industry events.

  • Andrew Todd
Optiscan Imaging has struck a deal to collaborate with the US-based University of Minnesota veterinary faculty on use of its imaging technology for animal companion oncological purposes.

Optiscan joins US vet school to trial cancer imaging on pets

Optiscan Imaging is moving into the veterinary space in a deal with US-based University of Minnesota to assess the use of its cancer imaging technology on pets.

  • James Pearson
Optiscan Imaging is getting set to go commercial with its remarkable medical imaging technology.

Telepathology milestone as Optiscan gets set for commerciality

Optiscan Imaging has developed a cloud-based platform for the remote diagnosis of cancer using its remarkable medical imaging device.

  • Andrew Todd
Advertisement
Optiscan Imaging’s cutting-edge “InVue” microscopic medical imaging device will be trialled on breast cancer patients.

Optiscan gets nod for in-surgery breast cancer imaging

Optiscan Imaging has received the nod of approval to start taking in-human images during surgery for breast cancer patients using its “InVue” technology.

  • Craig Nolan
Well-known WA business and horse racing identity Bob Peters believes Optiscan Imaging has its “hoof on the till” with its developing medical imaging devices.

Hoof on the till: Peters backs Optiscan med-tech

In an exclusive interview with Bulls N’ Bears, prominent WA business and thoroughbred horse racing identity Bob Peters reveals his passion for med-techs.

  • Steve Butler
Optiscan Imaging is making impressive progress with its medical imaging technology.

New Optiscan tech opens door to precision surgery market

Optiscan Imaging has unveiled its next-generation microscopic medical imaging device, with its new “InVue” technology aimed at the precision surgery market.

  • Michael Philipps

Original URL: https://www.smh.com.au/topic/oil-153